Skip to content

Clinical trials

Completed Phase 2/3 Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 2/3 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20071
20143
20171
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion2
Assiut University1
Daniels, Craig E., M.D.1
Human Adams1
Insmed Incorporated1
Post Graduate Institute of Medical Education and Research, Chandigarh1
Royal Brompton & Harefield NHS Foundation Trust1
Tokyo Medical and Dental University1
United Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial10
Scleroderma, Diffuse3
Dermatomyositis2
Hypertension, Pulmonary2
Idiopathic Pulmonary Fibrosis2
Polymyositis2
Pulmonary Fibrosis2
Connective Tissue Diseases1
Cough1
Emphysema1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.